Chinese Herbal Medicines and Active Metabolites: Potential Antioxidant Treatments for Atherosclerosis
- PMID: 34054550
- PMCID: PMC8155674
- DOI: 10.3389/fphar.2021.675999
Chinese Herbal Medicines and Active Metabolites: Potential Antioxidant Treatments for Atherosclerosis
Abstract
Atherosclerosis is a complex chronic disease that occurs in the arterial wall. Oxidative stress plays a crucial role in the occurrence and progression of atherosclerotic plaques. The dominance of oxidative stress over antioxidative capacity generates excess reactive oxygen species, leading to dysfunctions of the endothelium and accelerating atherosclerotic plaque progression. Studies showed that Chinese herbal medicines and traditional Chinese medicine (TCM) might regulate oxidative stress; they have already been used to treat diseases related to atherosclerosis, including stroke and myocardial infarction. This review will summarize the mechanisms of oxidative stress in atherosclerosis and discuss studies of Chinese herbal medicines and TCM preparations treating atherosclerosis, aiming to increase understanding of TCM and stimulate research for new drugs to treat diseases associated with oxidative stress.
Keywords: Chinese herbal medicines; anti-oxidant treatment; atherosclerosis; oxidative stress; traditional Chinese medicine.
Copyright © 2021 Song, Zhang, Lai, Li, Ju and Xu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Treatment of atherosclerosis by traditional Chinese medicine: Questions and quandaries.Atherosclerosis. 2018 Oct;277:136-144. doi: 10.1016/j.atherosclerosis.2018.08.039. Epub 2018 Aug 30. Atherosclerosis. 2018. PMID: 30212682 Review.
-
The role of Chinese herbal medicine in the regulation of oxidative stress in treating hypertension: from therapeutics to mechanisms.Chin Med. 2024 Oct 29;19(1):150. doi: 10.1186/s13020-024-01022-9. Chin Med. 2024. PMID: 39468572 Free PMC article. Review.
-
Multidirectional Intervention of Chinese Herbal Medicine in the Prevention and Treatment of Atherosclerosis: From Endothelial Protection to Immunomodulation.Am J Chin Med. 2024;52(4):925-947. doi: 10.1142/S0192415X24500381. Epub 2024 May 27. Am J Chin Med. 2024. PMID: 38798151 Review.
-
Roles of Chinese herbal medicines in ischemic heart diseases (IHD) by regulating oxidative stress.Int J Cardiol. 2016 Oct 1;220:314-9. doi: 10.1016/j.ijcard.2016.06.161. Epub 2016 Jun 25. Int J Cardiol. 2016. PMID: 27390948 Review.
-
Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.J Ethnopharmacol. 2020 Apr 6;251:112442. doi: 10.1016/j.jep.2019.112442. Epub 2019 Dec 28. J Ethnopharmacol. 2020. PMID: 31891799 Review.
Cited by
-
Dysfunction of Microcirculation in Atherosclerosis: Implications of Nitric Oxide, Oxidative Stress, and Inflammation.Int J Mol Sci. 2025 Jul 4;26(13):6467. doi: 10.3390/ijms26136467. Int J Mol Sci. 2025. PMID: 40650241 Free PMC article. Review.
-
Yiqi Wenyang decoction protects against the development of atherosclerosis by inhibiting vascular inflammation.Pharm Biol. 2025 Dec;63(1):264-274. doi: 10.1080/13880209.2025.2492650. Epub 2025 Apr 20. Pharm Biol. 2025. PMID: 40254717 Free PMC article.
-
Bioactive Macromolecule-mediated Biogenic FeONPs Attenuate Inflammation in Atherosclerotic Rat by Activating PI3K/Akt/eNOS Pathway.Curr Pharm Des. 2025;31(11):843-854. doi: 10.2174/0113816128298009240828062231. Curr Pharm Des. 2025. PMID: 39317998
-
Eburicoic acid inhibits endothelial cell pyroptosis and retards the development of atherosclerosis through the Keap1/Nrf2/HO‑1/ROS pathway.Mol Med Rep. 2025 Jul;32(1):186. doi: 10.3892/mmr.2025.13551. Epub 2025 May 2. Mol Med Rep. 2025. PMID: 40314092 Free PMC article.
-
Vascular Repair by Grafting Based on Magnetic Nanoparticles.Pharmaceutics. 2022 Jul 8;14(7):1433. doi: 10.3390/pharmaceutics14071433. Pharmaceutics. 2022. PMID: 35890328 Free PMC article. Review.
References
-
- Antoniades C., Shirodaria C., Crabtree M., Rinze R., Alp N., Cunnington C., et al. (2007). Altered Plasma versus Vascular Biopterins in Human Atherosclerosis Reveal Relationships between Endothelial Nitric Oxide Synthase Coupling, Endothelial Function, and Inflammation. Circulation 116 (24), 2851–2859. 10.1161/circulationaha.107.704155 - DOI - PubMed
-
- Antoniades C., Shirodaria C., Warrick N., Cai S., de Bono J., Lee J., et al. (2006). 5-methyltetrahydrofolate Rapidly Improves Endothelial Function and Decreases Superoxide Production in Human Vessels: Effects on Vascular Tetrahydrobiopterin Availability and Endothelial Nitric Oxide Synthase Coupling. Circulation 114 (11), 1193–201. 10.1161/circulationaha.106.612325 - DOI - PubMed
-
- Asadi A., Yaghobi Nezhad D., Rafie Javazm A., Khanicheragh P., Mashouri L., Shakeri F., et al. (2020). In Vitro Effects of Curcumin on Transforming Growth Factor-β-Mediated Non-smad Signaling Pathway, Oxidative Stress, and Pro-inflammatory Cytokines Production with Human Vascular Smooth Muscle Cells. Iran J. Allergy Asthma Immunol. 19 (1), 84–93. 10.18502/ijaai.v19i1.2421 - DOI - PubMed
-
- Barrett T. J., Distel E., Murphy A. J., Hu J., Garshick M. S., Ogando Y., et al. (2019). Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation. Circulation 140 (14), 1170–1184. 10.1161/circulationaha.119.039476 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources